Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Howard Blumstein, MD, Assumes RheumPAC Chair

Renée Bacher  |  November 18, 2021

I also want to spread the message of what advocacy is and what it isn’t. Advocacy is not about bribery. There’s nothing dirty about advocating for your patients and the future of your profession in terms of workforce, therapeutic advances and the financial viability of our practices. It’s our duty to do this, and we’re really supporting legislators who already support us by helping to keep them in office. 

TR: What are your goals for RheumPAC? 

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Blumstein: Primarily I want to develop innovative ways to engage the rest of the College. Zach Wallace, MD, MSc, our outgoing chair, has done a phenomenal job in terms of outreach and networking with other members. I’d like to find more ways to connect better with our academic colleagues and training programs. We have trainees going out into the world, and regardless of what career path they take, they’re going to be impacted by policy. They don’t necessarily have to go to Washington, D.C., but giving even $10—multiplied by the number of members in our College—will make a difference, especially if it’s consistent. 

Howard Blumstein stands with family members and two dogs

The Blumstein family

TR: Anything else you would like to share to help members get to know you? 

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Blumstein: Our family adopted our first-ever dog, Brad, at the beginning of the pandemic. He’s a 65 lb. Husky/Border Collie/beagle/Chow Chow/Bulldog mix. Last month we added Piper, a Chihuahua/terrier mix to our family. Both are from rescues. I have always wanted a dog, and we are all so happy with them.

Renée Bacher is a health and medical writer based in Louisiana.

Page: 1 2 | Single Page
Share: 

Filed under:Legislation & AdvocacyProfiles Tagged with:AdvocacyHoward BlumsteinRheumPACVolunteering

Related Articles

    N.Y. Rheumatologist Makes Advocacy a Priority

    August 16, 2017

    In 2005, not long after he became a private practice rheumatologist on Long Island, N.Y., Howard Blumstein, MD, dipped his toe into the advocacy pool at the encouragement of his partner, Max Hamburger, MD. “I thought it would be interesting to learn more about the issues that affect our patients and our practices, and I…

    I RheumPAC, Do You?

    September 1, 2009

    For many years, the ACR board of directors and Government Affairs Committee have done exemplary work in keeping members abreast of legislative regulatory issues that affect all aspects of rheumatology, including patient and physician/healthcare professional issues, education, and research. Through advocacy, the ACR advances rheumatology and fosters excellence in the care of people with, or at risk for, arthritis and rheumatic and musculoskeletal diseases. One might say that advocacy is a cornerstone of this organization.

    Advancing the ACR’s Legislative Priorities in 2021

    January 11, 2021

    With a new Congress and many new legislators in key leadership positions, your support today will help RheumPAC start the year off strong.

    November, a Busy Month for RheumPAC

    October 21, 2022

    In November, RheumPAC will be leading its annual matching campaign and hosting two events at ACR Convergence 2022. Thanks to matching donors, every contribution in November will be amplified.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences